News About: Pharm. Industry
Approvals for OTC medicines keep dropping
It was analyzed the number of approvals(registrations) for OTC medicine has continuously decreased since 2014.
According to the Ministry of Food and Drug Safety, the number of ETC medicines approved(registered) last ...
GreenCross MS supplies hemodialysis solutions of KRW 90 billion to Boryung Pharm
GreenCross Medical Science(CEO Young-Pil Kim, GreenCross MS) announced on the 19th it signed a long-term supply agreement of supplying hemodialysis solutions for 10 years with Boryung Pharm(CEO Tae-Hong Choi).
GreenC...
Janssen files patent infringement trial against Samsung BioepisJanssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis.
Janssen recently sued Samsung Bioepis for infringing the 3 patents of ...
|
Bukwang Pharm acquires joint license of Meditoxin Inj for treatment purpose from EisaiBukwang Pharm announced that it signed a co-marketing and distribution agreement with Eisai Korea for the co-sales and exclusive distribution license of ‘Meditoxin Inj 200 Units...
|
Celltrion’s active launching process for Truxima, starting to sell in GermanyCelltrion announced on the 18th that it has started to prepare for an official launch of ‘Truxima,’ the first antibody biosimilar for the treatment of blood cancer, even in Germ...
|
Female CEOs’ ‘Outstanding performance’ in management, marketing and R&D at listed pharmas
Although the female executive ratio is only 7% in listed pharmaceutical companies, they are evaluated to have outstanding performance with their active activities.
According to the Yakup Shinmoon’s(www.yakup.com) ana...
24 incrementally modified drugs newly approved last year, increased by 33%
The number of incrementally modified drugs approved last year was the total 24 products, increased by 33% compared to the year of 2015.
The Ministry of Food and Drug Safety revealed that 24 products were approved as ...
Hanmi Pharm acquires world’s first approval of combination drug for treatment of both asthma and allergic rhinitis
Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kown) announced on the 17th that it acquired commercialization approval of ‘Monterizine,’ a combination drug for patients with both asthma and allergic rhinitis(allergic rhiniti...
Female ratio to total executives was only 7% in listed pharmas
Less than 1 of 10 executives working for Korean listed pharmaceutical companies were women.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the executive status(including registered and unregister...
Dong Wha Pharm acquires license to sell all the GSK’s OTC products worth of KRW 55 billion
Dong Wha Pharm has risen as the strongest in selling OTC drugs.
According to the industry concerned, Dong Wha Pharm was known to sign an agreement of selling all the GSK’s OTC products(total 10 products) with GSK on ...
